Jci_page_head_homepage_01 Jci_page_head_homepage_02
Michael J. Owen, Nigel M. Williams, Michael C. O’Donovan
Published in Volume 113, Issue 9
J Clin Invest. 2004; 113(9):1255–1257 doi:10.1172/JCI21470
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

Schematic representation of a glutamatergic synapse. Several genes have been implicated in susceptibility to schizophrenia that can potentially impact on glutamate (Glu) synaptic function including dysbindin-1, neuregulin 1 (NRG1), G72, D-amino acid oxidase (DAAO), and regulator of G protein signalling 4 (RGS4). Dysbindin-1 may influence VGlutT-1 expression, synthesis, or degradation and is a component of the postsynaptic density (PSD). NRG1 is present in glutamate synaptic vesicles, regulates expression of N-methyl-D-aspartate receptors (NMDARs), activates ErbB4 receptors, which colocalize with NMDARs, and interacts with the PSD. G72 interacts with DAAO, which oxidizes D-serine, an endogenous modulator of NMDARs. RGS4 is a negative regulator of G protein_coupled receptors, especially the metabotropic glutamate receptor 5 (mGluR5), via its effects on the G protein Gq. Figure modified with permission from The Lancet (7).